Pupillary response changes in Graves' disease

被引:0
|
作者
Bicer, Gamze Yildirim [1 ]
Onder, Cagatay Emir [2 ]
Zor, Kursad Ramazan [1 ]
机构
[1] Nigde Omer Halisdemir Univ, Dept Ophthalmol, Sch Med, Nigde, Turkiye
[2] Nigde Training & Res Hosp, Endocrinol & Metab Dis Clin, Nigde, Turkiye
来源
CUKUROVA MEDICAL JOURNAL | 2023年 / 48卷 / 02期
关键词
Autonomic nervous system; Graves' disease; pupil dilatation speed; pupillometry; thyroid function tests; SYMPATHETIC OVERACTIVITY; METHIMAZOLE;
D O I
10.17826/cumj.1229467
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The aim of this study was to investigate pupillary contraction and dilatation response changes in Graves' disease. Materials and Methods: The patient group consisted of 55 euthyroid Graves patients and the control group consisted of 55 healthy individuals. Data from the right eyes of all participants were used. Static (scotopic, mesopic, photopic) and dynamic pupillometry measurements were performed with automatic pupillometry. The mean pupil dilatation speed was calculated according to dynamic measurements. Static measurements, dynamic measurements and the mean pupil dilatation speed data were compared between the patient and control groups.Results: There was no statistically significant difference between two groups in all static and dynamic values and the mean pupil dilatation speed. The mean scotopic pupil diameter was 5.41 & PLUSMN;0.776 mm in Graves' group and 5.55 & PLUSMN;0.747 mm in the control group. The mean mesopic pupil diameter was 4.39 & PLUSMN;0.721 in Graves' group and 4.17 & PLUSMN;0.640 mm in the control group. The mean photopic pupil diameter was 3.45 & PLUSMN;0,549 mm in Graves' group and 3.29 & PLUSMN;0.679 mm in the control group. The mean dynamic pupil diameter 0th second was 3, 54 & PLUSMN;0.541 mm in Graves' group and 3.48 & PLUSMN;0.708 mm in the control group. The mean speed of pupil dilatation at 18th second was 0.116 & PLUSMN;0.031 mm/sec in Graves' group and 0.128 & PLUSMN;0.040 mm/sec in the control group. Age was found to be an independent factor on pupillary parameters.Conclusion: The pupillary parameters of patients with euthyroid hormone levels were not affected. While pupillary responses appeared not to be affected in the case of euthyroidism, more studies including patients with hypothyroidism and hyperthyroidism are needed.
引用
收藏
页码:361 / 368
页数:8
相关论文
共 50 条
  • [21] Graves Disease
    Allelein, Stephanie
    Schott, Matthias
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2021, 146 (20) : 1337 - 1343
  • [22] Graves' disease in children and adolescents:: Response to long-term treatment
    Barrio, R
    López-Capapé, M
    Martinez-Badás, I
    Carrillo, A
    Moreno, JC
    Alonso, M
    ACTA PAEDIATRICA, 2005, 94 (11) : 1583 - 1589
  • [23] Pupillary response abnormalities in depressive disorders
    Laurenzo, Scott A.
    Kardon, Randy
    Ledolter, Johannes
    Poolman, Pieter
    Schumacher, Ashley M.
    Potash, James B.
    Full, Jan M.
    Rice, Olivia
    Ketcham, Anna
    Starkey, Cole
    Fiedorowicz, Jess G.
    PSYCHIATRY RESEARCH, 2016, 246 : 492 - 499
  • [24] Changes in Thyroid Peroxidase and Thyroglobulin Antibodies Might Be Associated with Graves' Disease Relapse after Antithyroid Drug Therapy
    Choi, Yun Mi
    Kwak, Mi Kyung
    Hong, Sang Mo
    Hong, Eun-Gyoung
    ENDOCRINOLOGY AND METABOLISM, 2019, 34 (03) : 268 - 274
  • [25] Pupillary response to representations of light in paintings
    Castellotti, Serena
    Conti, Martina
    Feitosa-Santana, Claudia
    Del Viva, Maria Michela
    JOURNAL OF VISION, 2020, 20 (10): : 1 - 18
  • [26] The Role of the Microbiota in Graves' Disease and Graves' Orbitopathy
    Hou, Jueyu
    Tang, Yunjing
    Chen, Yongjiang
    Chen, Danian
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2021, 11
  • [27] Characterising cerebrovascular reactivity and the pupillary light response-a comparative study
    Sparks, Sierra
    Hayes, Genevieve
    Pinto, Joana
    Bulte, Daniel
    FRONTIERS IN PHYSIOLOGY, 2024, 15
  • [28] Metabolite Changes during the Transition from Hyperthyroidism to Euthyroidism in Patients with Graves Disease '
    Lee, Ho Yeop
    Sim, Byeong Chang
    Nga, Ha Thi
    Moon, Ji Sun
    Tian, Jingwen
    Linh, Nguyen Thi
    Ju, Sang Hyeon
    Choi, Dong Wook
    Setoyama, Daiki
    Yi, Hyon-Seung
    ENDOCRINOLOGY AND METABOLISM, 2022, 37 (06) : 891 - 900
  • [29] Comparison of antithyroid drugs efficacy on P wave changes in patients with Graves' disease
    Berker, Dilek
    Isik, Serhat
    Caubay, Alper
    Aydin, Yusuf
    Tutuncu, Yasemin
    Delibasi, Tuncay
    Guler, Serdar
    ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY, 2009, 9 (04): : 298 - 303
  • [30] Clinical efficacy of Yingliu treatment for Graves disease
    Yang, Hua
    Bi, Xiaojuan
    Tang, Hong
    Zeng, Juanhua
    Cong, Yilei
    Wu, Tengfei
    Chen, Qiuye
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (04): : 6145 - 6153